Login to Your Account

BIO 2012 International Convention

BRIC Markets Have Stopped Emerging; They've Arrived

By Michael Harris
Senior Editor

Friday, June 22, 2012
BOSTON – Is it practical to still designate China – a market that is closing in on Japan as the world's second-largest pharma market – as a potential market? Or regard Russia's biopharma industry status as an emerging one, when its clinical trials infrastructure is rated in the global top five by the FDA?

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription